INTRODUCTION
The role of various physiological factors that regulate heme synthesis and/or influence the development of anemia in the bone marrow during lead (Pb) exposure has been sparsely investigated.
Previous studies in liver demonstrated that oxidized polyglutamate derivatives of folic acid protected against Pb inhibition of uroporphyrinogen I (URO) synthase (EC 4.3.1.8) [l] . As a result of the rather low levels of URO synthase activity found in liver and other tissues. it is believed that the synthesis of uroporphyrinogen may be potentially rate-limiting for the biosynthesis of heme.
Consequently, the endogenous folate content and regulation of pteroylpolyglutamate synthesis/catabolism are anticipated to be important factors modulating the susceptibility of bone marrow heme synthesis to inhibition by Pb [2] .
Most previous studies concerning the etiology of drug/toxicant-associated anemia and its relationship to the biosynthesis of heme have been conducted with the mature red blood cell, which is not actively engaged in heme synthesis. It is anticipated that more relevant information could be obtained by focusing study on the bone marrow. It is known that premature erythroid precursor cells are highly susceptible to the toxic effects of Pb. As a result of the complex cellular heterogeneity of bone marrow in vivo, controlled study of this cellular target is rather difficult. Murine erythroleukemia cells (MELC) are erythroid precursor cells which. when cultured in the presence of certain chemicals (e.g. DMSO, hexamethylene-bis(acetamide)
[HMBA]) [3, 4] , undergo changes similar to normal erythrocyte maturation, including the synthesis of heme and hemoglobin [5] . It is anticipated that MELC will be a useful in vitro model to study drug/toxicant interactions during erythropoiesis.
In the present study, this in vitro system was evaluated for its potential usefulness as a model to study folate regulation of uroporphyrinogen synthesis and heme formation in bone marrow during Pb exposure.
MATERIALS AND METHODS

Cell culture
The murine erythroleukemia cell line (MELC), clone 745A. was obtained from the Institute for Medical Research, Camden, NJ. Spinner cultures were maintained at 37°C in Iscove's minimum essential medium supplemented with 5 9;: (v/v/) defined bovine calf serum (Hyclone Laboratories, Inc.. Logan, UT). Induction of differentiation was achieved by addition of a stock solution of hexamethylene-bis(acetamide) (HMBA) (Sigma Chemical Co., St. Louis, MO) to a final medium concentration of 3 mM and maintenance of cultures for 4 days.
Subcellular fractionation
MELC pellets were lysed in distilled deionized water and homogenized in 50 mM Tris-HCl buffer (pH 8.0). After sequential centrifugation, the resulting 100000 x g supernatant (cytosol) served as the enzyme source. MELC cytosol was dialyzed for 24 h at 4°C against 100 x volume of buffer with 4 exchanges. Protein content was determined by the method of Lowry et al. [6] .
Uroporphyrinogen I (URO ) synthase activity
Cytosolic URO synthase activity was measured by a modification [7] of the method of Strand et al. [8] . Cytosol was incubated with 100 PM porphobilinogen (PBG) (Porphyrin Products, Logan, UT) in 50 mM Tris-HCl/SO mM KC1 (pH 7.8) at 37°C for 45 min. Following the addition of ethylacetate/acetic acid (2: l), 1 .O N HCl was added and the mixture shaken. After phase separation and standing for 30 min in room light, porphyrin fluorescence in the lower aqueous phase was determined and compared to a uroporphyrin I standard (Porphyrin Products) using a spectrophotofluorometer.
&Aminolevulinic acid dehydratase (ALA-D) activity
Cytosolic ALA-D activity was measured by the method of Gibson et al. [9] . The product, porphobilinogen (PBG), was measured spectrophotometrically (553 nm) after reaction with Ehrlich's reagent using a mM extinction coefficient of 61.
Effects of lead andpteroylpolyglutamates (PteGlu,) on enzyme activities
Pteroylpolyglutamates in oxidized form were obtained from Dr. N.G. Nair, University of South Alabama Medical Sciences Foundation, Mobile, AL. Pb as lead acetate and pteroylpolyglutamates as free acids were added to the incubation mixtures as described in the text. Pteroylpolyglutamates exhibited 95% homogeneity by glutamate chain length as determined by high-performance liquid chromatography (HPLC) as described by Shane [lo] .
Pteroylpolyglutamate distribution in MELC
Endogenous pteroylpolyglutamates in MELC extracts were quantitatively cleaved to p-aminobenzoylpolyglutamates and separated according to glutamate chain length by HPLC as described by Shane [lo] .
Statistics
Data were analyzed by Student's t-test to determine the significance of difference between means.
RESULTS AND DISCUSSION
The effect of Pb on uroporphyrinogen synthase was studied in MELC. The results showed that URO synthase activity in untreated cytosol was unaffected by incubation with 50 pM Pb ( Table I) . Dialysis of cytosol rendered URO synthase activity sensitive to Pb, showing an 80% decrease in activity in Pb-treated cytosol compared to controls. Thus, MELC cytosol exhibited similarities to hepatic cytosol with respect to the presence of a dialyzable factor conferring protection on URO synthase against inhibition by Pb [l]. The dialyzable factor was postulated to be a derivative of pteroylpolyglutamic acid.
To test this possibility, various pteroylpolyglutamates were tested for the ability to protect URO synthase against inhibition by Pb in dialyzed cytosol. Although all of the pteroylglutamates tested decreased control URO synthase activity somewhat, only pteroylpentaglutamate (PteGluS) was capable of conferring protection against Pb inhibition (Table I) . A rather high concentration (100 ,vM) of PteGlus was required to protect URO synthase from Pb inhibition.
One possible explanation is that the endogenous protective factor is a more potent biological derivative of PteGlus [I I]. The results in Figure I showed that the protection of URO synthase from Pb inhibition by PteGlus was rapid, with near control levels of uroporphyrinogen formation observed in the first 5 min of incubation.
Reduced glutathione (GSH), a dialyzable sulfhydryl compound, was also found to protect against Pb inhibition of URO synthase but only at millimolar concentrations. This concentration exceeded normal cytosolic GSH levels by at least IOO-fold (data not shown).
The specificity of PteGlus for protection of URO synthase against Pb inhibition was examined by testing the ability of PteGluS to protect another heme biosynthetic enzyme known to be extremely sensitive to Pb, S-aminolevulinic acid dehydratase (ALA-D) [9] . PteGlus failed to protect against a Pb-mediated decrease in ALA-D activity (Table II) , suggesting that the protective effect was specific for URO synthase and not merely a Pb-chelating function [I]. Analysis of the distribution of endogenous pteroylglutamates in MELC revealed a mixture of pteroylmono-, tetra-, penta-and hexaglutamate, with pentaglutamate predominating (> 50% of total endogenous pteroylglutamate) (Fig. 2) . Thus, by glutamate chain length, the pteroylpolyglutamate which protected URO synthase against Pb inhibition was the predominant endogenous form. Identification of the exact structure of this endogenous pteridine should aid in elucidating the specific mechanism of protection of URO synthase. Such studies are currently in progress. These initial studies demonstrate the potential usefulness of MELC to study the role of endogenous folate content and the regulation of pteroylpolyglutamate synthesis on uroporphyrinogen synthesis and heme formation in bone marrow during Pb exposure.
